Voting
Your vote is important!
Vote online now or by dialing 844-927-1815.
June 3, 2026
10:00 a.m. Pacific Time
Our mission is to discover and develop effective biologic therapeutics for people with life-threatening conditions.
Toward this goal, we’ve developed a diverse pipeline of therapeutic candidates specifically designed to leverage the power of our core sdAb (single-domain antibody) platform and protein-engineering expertise.